Clinical trials
Disease Progression trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Brompton & Harefield NHS Foundation Trust | 2 |
| AGC Biologics S.p.A. | 1 |
| AVEO Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Barts & The London NHS Trust | 1 |
| Biogen | 1 |
| Eli Lilly and Company | 1 |
| Ferrer Internacional S.A. | 1 |
| Heidelberg University | 1 |
| Janssen-Cilag International NV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 23 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Bronchitis, Chronic | 2 |
| Carcinoma, Renal Cell | 2 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Kidney Failure, Chronic | 2 |
| Lung Diseases | 2 |
| Lung Diseases, Obstructive | 2 |
| Pulmonary Emphysema | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.